Eton Pharmaceuticals, Inc. (ETON)
34.46
+1.57
(+4.77%)
USD |
NASDAQ |
May 20, 16:00
34.45
-0.01
(-0.03%)
After-Hours: 05:06
Eton Pharmaceuticals EPS Diluted (Quarterly) : 0.0493 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Harrow, Inc. | -0.7414 |
| Daré Bioscience, Inc. | -0.2066 |
| cbdMD, Inc. | -0.084 |
| Corcept Therapeutics, Inc. | -0.2988 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.554M |
| Revenue (Quarterly) | 24.27M |
| Total Expenses (Quarterly) | 22.71M |
| Enterprise Value | 912.54M |
| Gross Profit Margin (Quarterly) | 60.72% |
| Profit Margin (Quarterly) | 6.40% |
| Earnings Yield | -0.21% |
| Operating Earnings Yield | 0.23% |
| Normalized Earnings Yield | -0.1866 |